GlassScriptPhysician profile
Ali Ayoubi
NPI 1104948017
$5,766.93
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.61 · 2020: $491 · 2021: $363 · 2022: $4,311 · 2023: $284 · 2024: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $284 · Long Term Medical Supply Or Device Loan: $247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $283.53 |
| Long Term Medical Supply Or Device Loan | $246.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,017.71 | 2022 | |
| Abbott Laboratories | $704.65 | 2019-2023 | Merlin@Home |
| Baxter Healthcare | $246.97 | 2024 | Hillrom - Spot Vision Screener |
| Amgen INC. | $150.27 | 2020-2022 | |
| Cook Medical LLC | $142.79 | 2021-2023 | Zilver Ptx |
| Medtronic Vascular, INC. | $140.24 | 2020 | |
| Boston Scientific Corporation | $77.54 | 2023 | Watchman Flx |
| Novartis Pharmaceuticals Corporation | $68.54 | 2020-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $48.60 | 2019-2023 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.87 | 2021 | |
| Avinger INC. | $38.12 | 2021-2023 | Pantheris |
| Cvrx, INC. | $36.02 | 2021 | |
| Heartflow, INC. | $18.51 | 2019 | |
| Merck Sharp & Dohme LLC | $15.76 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $14.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Ayoubi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.